Gene H Resnick

US Patent:

20030064949, Apr 3, 2003

Filed:

Feb 28, 2002

Appl. No.:

10/086294

Inventors:

Loretta Nielsen - Millington NJ, US
Jo Horowitz - Kenilworth NJ, US
Daniel Maneval - San Diego CA, US
G. Demers - San Diego CA, US
Mary Rybak - Warren NJ, US
Gene Resnick - Scarsdale NY, US

International Classification:

A61K048/00
A61K038/17
A61K031/337
A61K031/28

US Classification:

514/044000, 514/012000, 514/492000, 514/449000

Abstract:

In one embodiment, this invention provides methods of treating mammalian cancer or hyperproliferative cells, said method comprising contacting said cells with a tumor suppressor protein or tumor suppressor nucleic acid and also contacting said cell with at least one adjunctive anti-cancer agent. The invention also provides for a pharmacological composition comprising a tumor suppressor protein or a tumor suppressor nucleic acid and at least one adjunctive anti-cancer agent, and a kit for the treatment of mammalian cancer or hyperproliferative cells.

US Patent:

20040235736, Nov 25, 2004

Filed:

Apr 13, 2004

Appl. No.:

10/824058

Inventors:

Loretta Nielsen - Millington NJ, US
Jo Horowitz - Kenilworth NJ, US
Daniel Maneval - San Diego CA, US
G. Demers - San Diego CA, US
Mary Rybak - Warren NJ, US
Gene Resnick - Scarsdale NY, US

Assignee:

CANJI, INC. - SAN DIEGO CA

International Classification:

A61K038/17
A61K048/00

US Classification:

514/012000, 514/044000

Abstract:

In one embodiment, this invention provides methods of treating mammalian cancer or hyperproliferative cells, said method comprising contacting said cells with a tumor suppressor protein or tumor suppressor nucleic acid and also contacting said cell with at least one adjunctive anti-cancer agent. The invention also provides for a pharmacological composition comprising a tumor suppressor protein or a tumor suppressor nucleic acid and at least one adjunctive anti-cancer agent, and a kit for the treatment of mammalian cancer or hyperproliferative cells.

US Patent:

20070014768, Jan 18, 2007

Filed:

Jul 25, 2006

Appl. No.:

11/493429

Inventors:

Loretta Nielson - Millington NJ, US
Jo Horowitz - Kenilworth NJ, US
Daniel Maneval - San Diego CA, US
G. Demers - San Diego CA, US
Mary Rybak - Warren NJ, US
Gene Resnick - Scarsdale NY, US

Assignee:

Canji, Inc. - San Diego CA

International Classification:

A61K 48/00
A61K 38/19

US Classification:

424093200, 514044000, 424085100

Abstract:

In one embodiment, this invention provides methods of treating mammalian cancer or hyperproliferative cells, said method comprising contacting said cells with a tumor suppressor protein or tumor suppressor nucleic acid and also contacting said cell with at least one adjunctive anti-cancer agent. The invention also provides for a pharmacological composition comprising a tumor suppressor protein or a tumor suppressor nucleic acid and at least one adjunctive anti-cancer agent, and a kit for the treatment of mammalian cancer or hyperproliferative cells.

US Patent:

20070122379, May 31, 2007

Filed:

Nov 29, 2006

Appl. No.:

11/564489

Inventors:

Loretta Nielsen - Millington NJ, US
Jo Horowitz - Kenilworth NJ, US
Daniel Maneval - San Diego CA, US
G. Demers - San Diego CA, US
Mary Rybak - Warren NJ, US
Gene Resnick - Scarsdale NY, US

Assignee:

Canji, Inc. - San Diego CA

International Classification:

A61K 38/19
A61K 39/395

US Classification:

424085100, 424155100

Abstract:

In one embodiment, this invention provides methods of treating mammalian cancer or hyperproliferative cells, said method comprising contacting said cells with a tumor suppressor protein or tumor suppressor nucleic acid and also contacting said cell with at least one adjunctive anti-cancer agent. The invention also provides for a pharmacological composition comprising a tumor suppressor protein or a tumor suppressor nucleic acid and at least one adjunctive anti-cancer agent, and a kit for the treatment of mammalian cancer or hyperproliferative cells.

US Patent:

20080286239, Nov 20, 2008

Filed:

May 28, 2008

Appl. No.:

12/128450

Inventors:

Loretta Nielsen - Millington NJ, US
Jo Ann Horowitz - Kenilworth NJ, US
Daniel C. Maneval - San Diego CA, US
G. William Demers - San Diego CA, US
Mary Ellen Rybak - Warren NJ, US
Gene Resnick - Scarsdale NY, US

Assignee:

Canji, Inc. - San Diego CA

International Classification:

A61K 35/76
A61K 31/711
A61P 35/04

US Classification:

424 932, 514 44

Abstract:

In one embodiment, this invention provides methods of treating mammalian cancer or hyperproliferative cells, said method comprising contacting said cells with a tumor suppressor protein or tumor suppressor nucleic acid and also contacting said cell with at least one adjunctive anti-cancer agent. The invention also provides for a pharmacological composition comprising a tumor suppressor protein or a tumor suppressor nucleic acid and at least one adjunctive anti-cancer agent, and a kit for the treatment of mammalian cancer or hyperproliferative cells.

US Patent:

20030060434, Mar 27, 2003

Filed:

May 13, 1999

Appl. No.:

09/311772

Inventors:

LORETTA NIELSEN - MILLINGTON NJ, US
JO ANN HOROWITZ - KENILWORTH NJ, US
DANIEL C. MANEVAL - SAN DIEGO CA, US
G. WILLIAM DEMERS - SAN DIEGO CA, US
MARY ELLEN RYBAK - WARREN NJ, US
GENE RESNICK - SCARSDALE NY, US

International Classification:

A61K048/00

US Classification:

514/044000

Abstract:

In one embodiment, this invention provides methods of treating mammalian cancer or hyperproliferative cells, said method comprising contacting said cells with a tumor suppressor protein or tumor suppressor nucleic acid and also contacting said cell with at least one adjunctive anti-cancer agent. The invention also provides for a pharmacological composition comprising a tumor suppressor protein or a tumor suppressor nucleic acid and at least one adjunctive anti-cancer agent, and a kit for the treatment of mammalian cancer or hyperproliferative cells.